CompanyGraph
RaySearch Laboratories AB
RAY.B · Nasdaq Stockholm · Sweden
Price data from its RAYBs listing on CBOE
raysearchlabs.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 5.8: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.21%
Annual Rate
SEK 4.00Paid unknown
Payout Ratio
64.2%Moderate
Last Ex-Dividend
May 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.39BSEK780.83M · vs all stocks (USD)
Trailing P/E
29.44xvs Health Information Services peers
Revenue (TTM)
1.27BSEK134.22M · vs all stocks (USD)
Profit Margin
16.77%vs Health Information Services peers
Beta
0.9230xvs all stocks
52-Week Change
-31.31%vs all stocks
Forward Annual Dividend Yield
2.21%vs all stocks
Market Capitalization
7.39BSEK780.83M · vs all stocks (USD)
Enterprise Value
6.24BSEK659.25M · vs all stocks (USD)
Trailing P/E
29.44xvs Health Information Services peers
Forward P/E
27.33xvs Health Information Services peers
PEG Ratio
-4.44xPrice to Sales (TTM)
4.30xvs Health Information Services peers
Price to Book (MRQ)
6.03xvs Health Information Services peers
Enterprise to Revenue
4.91xvs Health Information Services peers
Enterprise to EBITDA
18.12xvs Health Information Services peers
Gross Margin
91.90%vs Health Information Services peers
Profit Margin
16.77%vs Health Information Services peers
Operating Margin
10.32%vs Health Information Services peers
Return on Assets (TTM)
10.32%vs Health Information Services peers
Return on Equity (TTM)
26.02%vs Health Information Services peers
Revenue (TTM)
1.27BSEK134.22M · vs all stocks (USD)
Revenue per Share (TTM)
37.14SEKUpdated Aug 22, 2026Quarterly Revenue Growth
-10.70%vs Health Information Services peers
Gross Profit (TTM)
1.18BSEK124.84M · vs all stocks (USD)
EBITDA (TTM)
284.96MSEK30.12M · vs all stocks (USD)
Net Income (TTM)
213.00MSEK22.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-36.40%vs Health Information Services peers
Operating Cash Flow (TTM)
419.80MSEK44.37M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
130.91MSEK13.84M · vs all stocks (USD)
Forward Annual Dividend Rate
4.00SEKUpdated Aug 22, 2026Forward Annual Dividend Yield
2.21%vs all stocks
Trailing Annual Dividend Rate
4.00SEKUpdated Aug 22, 2026Trailing Annual Dividend Yield
2.21%vs all stocks
Payout Ratio
64.21%vs Health Information Services peers
Revenue
1.34BSEKFY2025 · Dec 31, 2025Cost of Goods Sold
101.90MSEKFY2025 · Dec 31, 2025Gross Profit
1.24BSEKFY2025 · Dec 31, 2025Operating Income
292.40MSEK30.90M · vs all stocks (USD)
Pre-tax Income
287.80MSEKFY2025 · Dec 31, 2025Income Tax Expense
60.00MSEKFY2025 · Dec 31, 2025Net Income
227.80MSEKFY2025 · Dec 31, 2025EBIT
292.40MSEKFY2025 · Dec 31, 2025EBITDA (Income Statement)
292.40MSEKFY2025 · Dec 31, 2025Research & Development
270.40MSEKFY2025 · Dec 31, 2025Selling, General & Administrative
650.20MSEKFY2025 · Dec 31, 2025Other Operating Expenses
39.60MSEKFY2025 · Dec 31, 2025EPS (Basic)
6.65SEKFY2025 · Dec 31, 2025EPS (Diluted)
6.65SEKFY2025 · Dec 31, 2025Basic Shares Outstanding
34.28MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
34.28MSharesFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SEKFY2025 · Dec 31, 2025Operating Cash Flow
146.00MSEKFY2025 · Dec 31, 2025Free Cash Flow
117.90MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
407.30MSEKFY2025 · Dec 31, 2025Starting Profit (CF Statement)
287.80MSEKFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-71.40MSEKFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-70.40MSEKFY2025 · Dec 31, 2025Capital Expenditures
-28.10MSEKFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00SEKFY2025 · Dec 31, 2025Net Investing Cash Flow
-28.10MSEKFY2025 · Dec 31, 2025Common Dividends Paid
-102.80MSEKFY2025 · Dec 31, 2025Other Financing Charges
-100.00KSEKFY2025 · Dec 31, 2025Net Financing Cash Flow
-102.90MSEKFY2025 · Dec 31, 2025Shares Outstanding
34.28MSharesUpdated Aug 22, 2026Float Shares
27.40MSharesUpdated Aug 22, 2026% Held by Insiders
10.85%vs all stocks
% Held by Institutions
55.54%vs all stocks
Total Cash (MRQ)
213.10MSEK22.52M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.34SEKUpdated Aug 22, 2026Total Debt (MRQ)
359.20MSEK37.96M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4556xvs Health Information Services peers
Current Ratio (MRQ)
1.29xvs Health Information Services peers
Book Value per Share (MRQ)
30.41SEKUpdated Aug 22, 2026Total Assets
1.99BSEK210.55M · vs all stocks (USD)
Total Current Assets
970.70MSEKFY2025 · Dec 31, 2025Total Liabilities
1.01BSEKFY2025 · Dec 31, 2025Total Non-current Assets
1.02BSEKFY2025 · Dec 31, 2025Total Non-current Liabilities
436.80MSEKFY2025 · Dec 31, 2025Total Current Liabilities
569.90MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents
407.30MSEKFY2025 · Dec 31, 2025Accounts Receivable
239.60MSEKFY2025 · Dec 31, 2025Inventory
22.00MSEKFY2025 · Dec 31, 2025Accounts Payable
35.40MSEKFY2025 · Dec 31, 2025Short-term Debt
77.50MSEKFY2025 · Dec 31, 2025Other Current Liabilities
101.10MSEKFY2025 · Dec 31, 2025Long-term Debt
317.30MSEKFY2025 · Dec 31, 2025Other Non-current Liabilities
900.00KSEKFY2025 · Dec 31, 2025Total Shareholders' Equity
985.30MSEK104.14M · vs all stocks (USD)
52-Week Low
153.10SEKUpdated Aug 22, 202652-Week High
275.50SEKUpdated Aug 22, 202652-Week Change
-31.31%vs all stocks
Beta
0.9230xvs all stocks
50-Day MA
199.10SEKUpdated Aug 22, 2026200-Day MA
203.82SEKUpdated Aug 22, 2026Avg 10-Day Volume
315.19KSharesUpdated Aug 22, 2026Avg 30-Day Volume
263.27KSharesUpdated Aug 22, 2026Diluted EPS (TTM)
6.23SEKUpdated Aug 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.8: safe zoneNotable
Altman Z-Score: 5.80
High earnings qualityNotable
Earnings Quality Score: 0.70
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
B-Soft Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Sinodata Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow
Newgen Software Technologies Ltd.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
Sichuan Jiuyuan Yinhai Software Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Ucap Cloud Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Ming Yuan Cloud Group Holdings Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Fujian Foxit Software Development Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Inspur Software Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow
Beijing Deep Glint Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
SGSG Science & Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Spectra Systems Corporation
2 interpretationsMulti-Year FCF With Growth And MarginROE, ROA, And Operating ROA Elevated
Clas Ohlson AB
2 interpretationsMulti-Year FCF With Growth And MarginROE, ROA, And Operating ROA Elevated
VT Co., Ltd.
2 interpretationsMulti-Year FCF With Growth And MarginROE, ROA, And Operating ROA Elevated